688600 Anhui Wanyi Science And Technology
- 15.59
- -0.49-3.05%
Anhui Wanyi Science And Technology News
Express News | Star closing review: The instrument and meter sector is strong while robot concept stocks have declined.
Express News | Anhui Wanyi Science and Technology: increase the total amount of funds for repurchasing shares and extend the repurchase period.
Third Quarter Report 2024
anhui wanyi science and technology (688600.SH) released its performance for the first three quarters, with a net loss of 26.6831 million yuan
Anhui Wanyi Science and Technology (688600.SH) released the third quarter report for 2024, during the reporting period the company achieved revenue...
Anhui Wanyi Science and Technology (688600.SH): The net loss was 26.6831 million yuan in the first three quarters.
On October 24, Guolonghui reported that Anhui Wanyi Science and Technology (688600.SH) announced that the company's revenue for the first three quarters was 0.456 billion yuan, a year-on-year decrease of 9.77%; the net income attributable to shareholders of listed companies was -26.6831 million yuan; basic earnings per share was -0.20 yuan.
Express News | Anhui Wanyi Science and Technology: Received government subsidies of 6 million yuan.
China Approves Anhui Wanyi Science and Technology's Ultrasonic Soft Tissue Surgery Equipment
anhui wanyi science and technology (688600.SH): obtained a medical instrument production license.
On September 19, Gelonhui announced that Anhui Wanyi Science and Technology (688600.SH) has received the medical device registration certificate for ultrasound soft tissue surgical equipment issued by the National Medical Products Administration. The specific details can be found in the announcement "Announcement of Anhui Wanyi Science and Technology Co., Ltd. on Voluntary Disclosure of Obtaining Medical Device Registration Certificate" disclosed on the website of the Shanghai Stock Exchange on September 7, 2024. The company recently received the "Medical Device Production License" issued by the Anhui Provincial Drug Administration. The acquisition of the "Medical Device Production License" provides qualification guarantee for the future formal production and market sales of products, and the company will actively carry out micro...
Express News | Anhui Wanyi Science and Technology: Obtained the medical device registration certificate for ultrasound soft tissue surgical equipment.
Half-year report for the year 2024.
Summary of Half-Year Report in 2024.
Anhui Wanyi Science and Technology (688600.SH): a net loss of 28.86 million yuan in the first half of the year, turning losses year-on-year.
Anhui Wanyi Science and Technology (688600.SH) released its semi-annual report on August 23rd. The revenue was 0.297 billion yuan, a decrease of 4.43% year-on-year. The net loss was 28.86 million yuan, a year-on-year loss. The non-GAAP net loss was 36.42 million yuan, a year-on-year loss. The basic earnings per share was -0.21 yuan.
Anhui Wanyi Science and Technology (688600.SH): has cumulatively repurchased 4.44% of its shares.
Anhui Wanyi Science and Technology (688600.SH) announced on August 2nd that as of July 31st, 2024, the company has cumulatively repurchased 5,981,226 shares through centralized bidding, accounting for 4.44% of the company's total share capital of 134,708,490 shares. The highest purchase price was 21.56 yuan/share and the lowest was 11.16 yuan/share. The total amount paid was 99,001,940.93 yuan (excluding stamp duty, transaction commission and other fees).
Anhui Wanyi Science and Technology (688600.SH): Plans to use up to 0.23 billion yuan of temporarily unused raised funds for cash management.
On July 12th, Glon Hui announced that Anhui Wanyi Science and Technology (688600.SH) held the 14th meeting of the fifth board of directors and the 12th meeting of the fifth supervisory board on July 12, 2024, and approved the proposal on the use of temporarily idle funds for cash management, agreeing that the company can use the temporarily idle funds raised, up to a maximum of RMB 230 million, for cash management, while ensuring that it does not affect the implementation of investment projects and ensuring the safety of raised funds. The funds will be used to purchase investment products with high safety, good liquidity, and guaranteed principal (including but not limited to structured products).
Anhui Wanyi Science and Technology (688600.SH) annual equity distribution in 2023: 2 yuan per 10 shares, registered on June 14th.
Anhui Wanyi Science and Technology (688600.SH) released the implementation announcement of the annual equity distribution for 2023, and distributed profits based on the total share capital on the equity distribution registration day (deducting the number of shares held by the company's share repurchase special securities account) to all shareholders, with a cash dividend of 2 yuan (including tax) for every 10 shares. The registration date for equity distribution is June 14, 2024, and the ex-rights (ex-dividend) date is June 17, 2024.
Anhui Wanyi Science and Technology (688600.SH) has spent 99.0019 million yuan to repurchase 4.44% of its shares.
Anhui Wanyi Science and Technology (688600.SH) announced that as of May 31, 2024, the company has passed the centralized bidding...
Wanyi Technology (688600) First Coverage Report: Scientific Instruments Little Giant Product Line Broadens and Superimposes High-End Products to Help Domestic Substitution
As a leader in domestic replacement of chromatographs, the company is expected to greatly benefit from the policy of localizing scientific instruments and upgrading equipment. We are optimistic that the release of the company's high-end analytical instruments will become the company's second growth curve to help accelerate performance and expand the layout of the life science circuit
Wanyi Technology (688600): Leak detectors are increasing, and R&D investment is increasing to save energy for growth
Core view: Net profit not attributable to mother grew rapidly in '23, and operating cash flow was drastically corrected. The company released the 2023 report and the 2024 quarterly report: the company achieved revenue of 787 million yuan in 23 (+16.50% year-on-year)
Wanyi Technology (688600): Cost control results are beginning to show, continue to increase R&D energy for long-term development
Incident: The company released its 2023 annual report and 2024 quarterly report. In 2023, the company achieved revenue of 787 million yuan, an increase of 16.5% over the previous year; realized net profit of 44 million yuan, a year-on-year decrease of 8.37 million yuan
Wanyi Technology (688600.SH): Net profit of 43.811 million yuan in 2023, plans to distribute 10 to 2 yuan
On April 27, Ge Longhui Technology (688600.SH) released its 2023 annual report. During the reporting period, it achieved operating income of 787 million yuan, an increase of 16.50% over the previous year; realized net profit attributable to shareholders of listed companies of 43.811 million yuan, a year-on-year decrease of 8.37%; and realized net profit attributable to shareholders of listed companies after deducting non-recurring profits and losses of 248.46,800 yuan, an increase of 139.31% over the previous year. It is proposed to distribute a cash dividend of 2.00 yuan (tax included) for every 10 shares to all shareholders. During the reporting period, revenue increased by 16.50% over the same period last year, mainly due to the company's approval
No Data